Paratek Pharmaceuticals Inc (PRTK) Inventory Turnover Ratio, from first quarter 2023 to first quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Paratek Pharmaceuticals Inc   (NASDAQ: PRTK)
 

Paratek Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Paratek Pharmaceuticals Inc inventory turnover ratio, the Paratek Pharmaceuticals Inc 's ability to sell and replace its inventory in the first quarter 2023, sequentially increased to 1.6 in the first quarter 2023, PRTK's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Paratek Pharmaceuticals Inc in Mar 31 2023 quarter, has decreased to 228 days, compare to 250 days, in the Dec 31 2022 quarter.

Within Healthcare sector 289 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2023, to 1253, from total ranking in the fourth quarter 2022 at 1748.

PRTK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Paratek Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRTK Inventory Turnover Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Inventory Growth 9.87 % 50.32 % 135.15 % 64.48 % -10.38 %
Y / Y Cost of Sales Growth 78.71 % 118.61 % 1.94 % -50.11 % 27.01 %
Inventory Turnover Ratio (TTM) 1.6 1.46 1.21 1.52 2.2
PRTK's Total Ranking # 1253 # 1748 # 1760 # 1358 # 1675
Average inventory processing period 228 250 301 240 166
Seq. Inventory Growth -15.55 % -20.17 % 58.6 % 2.76 % 15.54 %
Seq. Cost of Sales Growth -39.45 % 135.86 % -10.37 % 39.61 % -25.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 88
Healthcare Sector # 290
Overall Market # 1253

Inventory Turnover Ratio Statistics
High Average Low
2.2 1.15 0.46
(Mar 31 2022)   (Mar 31 2020)



PRTK Company Profile >> Back to PRTK Efficiency Comparisons >> Compare PRTK Inventory Turnover Ratio to its Competitors

Financial Statements
Paratek Pharmaceuticals Inc 's Inventories $ 14 Millions Visit PRTK's Balance sheet
Paratek Pharmaceuticals Inc 's Cost of Revenues TTM $ 26 Millions Visit PRTK's Income Statement
What are PRTK's Sales? Visit PRTK's Sales by Segment

Other Inventory Turnover Ratios
Paratek Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PRTK's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PRTK's Competitors
Inventory Turnover Ratio for PRTK's Suppliers
Inventory Turnover Ratio for PRTK's Customers

You may also want to know
PRTK's Sales Growth Rates PRTK's Pe Price to earnings ratio PRTK's Receivables Turnover Ratio PRTK's Stock Quote
PRTK's Net Income Growth Rates PRTK's Ps Price to Sales ratio PRTK's Sales per Employee PRTK's Asset Turnover Ratio
PRTK's Net Margin PRTK's Pb Price to Book ratio PRTK's Financial Strength Ratios PRTK's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Exact Sciences Corporation  5.05 $ 596.555  Millions$ 118  Millions
Neptune Wellness Solutions Inc   5.03 $ 45.695  Millions$ 9  Millions
Horizon Therapeutics Public Limited Company  5.02 $ 913.698  Millions$ 182  Millions
Abbvie Inc   4.96 $ 17,348.000  Millions$ 3,495  Millions
Sanuwave Health Inc   4.92 $ 5.256  Millions$ 1  Millions
Incyte Corporation  4.83 $ 221.205  Millions$ 46  Millions
Catalyst Pharmaceuticals Inc   4.79 $ 38.449  Millions$ 8  Millions
Inspire Medical Systems inc   4.71 $ 75.999  Millions$ 16  Millions
Lifemd Inc   4.68 $ 16.068  Millions$ 3  Millions
Henry Schein Inc   4.63 $ 8,704.000  Millions$ 1,881  Millions
Cytosorbents Corporation  4.57 $ 15.672  Millions$ 3  Millions
Precision Optics Corporation Inc   4.55 $ 13.186  Millions$ 3  Millions
Vystar Corporation  4.51 $ 7.531  Millions$ 2  Millions
Invacare Holdings Corporation  4.50 $ 534.718  Millions$ 119  Millions
Eargo Inc   4.47 $ 24.188  Millions$ 5  Millions
Bristol myers Squibb Company  4.47 $ 10,232.000  Millions$ 2,290  Millions
Catalent Inc   4.45 $ 3,332.300  Millions$ 749  Millions
Organogenesis Holdings Inc   4.35 $ 106.789  Millions$ 25  Millions
Integrated Biopharma Inc  4.33 $ 46.474  Millions$ 11  Millions
Harrow Inc   4.25 $ 27.691  Millions$ 7  Millions
Lftd Partners Inc   4.24 $ 31.814  Millions$ 7  Millions
Steris Plc  4.22 $ 2,798.147  Millions$ 664  Millions
West Pharmaceutical Services Inc   4.18 $ 1,760.600  Millions$ 422  Millions
Teva Pharmaceutical Industries Limited  4.17 $ 8,110.000  Millions$ 1,943  Millions
Agape Atp Corporation  4.04 $ 0.721  Millions$ 0  Millions
Biomerica Inc   4.01 $ 8.494  Millions$ 2  Millions
Rayont Inc   4.01 $ 1.824  Millions$ 0  Millions
Novocure Limited  3.98 $ 116.754  Millions$ 29  Millions
T2 Biosystems Inc   3.95 $ 18.891  Millions$ 5  Millions
Warby Parker Inc   3.94 $ 270.655  Millions$ 69  Millions

Date modified: 2026-08-29T17:22:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.